News | December 04, 2007

U.K. Will Use MRIs on All Stroke Symptom Patients

December 5, 2007 - The United Kingdom's Department of Health said today it will begin a new stroke strategy in which anyone in a higher-risk group who suffers a minor stroke will receive an MRI scan within 24 hours to accelerate the emergency response.

The department hopes the new strategy will help prevent up the 6,800 deaths and cases of disability, which occur due to strokes in the U.K. annually. A further 1,600 strokes may also be averted through preventative work, the department said.

Key measures include MRI scans for higher-risk individuals with Transient Ischaemic Attack (TIA), also known as minor strokes, within 24 hours of experiencing symptoms and within seven days for low-risk individuals. Department officials said this could lead to an 80 percent reduction in the number of people who go on to have a full stroke. Currently, less than 35 per cent of providers in the U.K. manage to treat TIA within seven days.

The new strategy also calls for the immediate transfer of those with suspected stroke to a specialist center offering immediate clinical assessment, scans and clot-busting drugs. All local areas will have 24/7 coverage by at least one specialist center.

"This is a bold vision for the delivery of world-class stroke services,from prevention right through to life-long support. There is no excuse for standing still," said Health Secretary Alan Johnson.

Stroke is the third biggest killer in England, with 50,000 people dying from it each year.

The program includes training for stroke consultants, nurses and allied health professionals, development of acute and community demonstration sites to pioneer best practice, and awareness campaigns with a funding package of about $194 million.

For more information: www.doh.gov.uk

Related Content

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.